Article info

Download PDFPDF

Original research
Pausing methotrexate prevents impairment of Omicron BA.1 and BA.2 neutralisation after COVID-19 booster vaccination

Authors

  • Elisa Habermann Department of Rheumatology and Clinical Immunology, Charité Universitätsmedizin Berlin Campus Charite Mitte, Berlin, Germany PubMed articlesGoogle scholar articles
  • Lutz Gieselmann Laboratory of Experimental Immunology, Institute of Virologie, University Hospital Cologne, 50931 Cologne, GermanyCenter for Molecular Medicine Cologne (CMMC), University of Cologne, 50931 Cologne, GermanyPartner site Bonn-Cologne, German Centre for Infection Research, 50931 Cologne, Germany PubMed articlesGoogle scholar articles
  • Pinkus Tober-Lau Department of Infectious Diseases and Respiratory Medicine, Charité Universitätsmedizin Berlin Campus Charite Mitte, Berlin, Germany PubMed articlesGoogle scholar articles
  • Jens Klotsche Epidemiology Unit, German Rheumatism Research Center, Berlin, Germany PubMed articlesGoogle scholar articles
  • Fredrik Nils Albach Department of Rheumatology and Clinical Immunology, Charité Universitätsmedizin Berlin Campus Charite Mitte, Berlin, Germany PubMed articlesGoogle scholar articles
  • Alexander ten Hagen Department of Rheumatology and Clinical Immunology, Charité Universitätsmedizin Berlin Campus Charite Mitte, Berlin, Germany PubMed articlesGoogle scholar articles
  • Jan Zernicke Department of Rheumatology and Clinical Immunology, Charité Universitätsmedizin Berlin Campus Charite Mitte, Berlin, Germany PubMed articlesGoogle scholar articles
  • Elvin Ahmadov Laboratory of Experimental Immunology, Institute of Virologie, University Hospital Cologne, 50931 Cologne, Germany PubMed articlesGoogle scholar articles
  • Amanthi Nadira Arumahandi de Silva Department of Rheumatology and Clinical Immunology, Charité Universitätsmedizin Berlin Campus Charite Mitte, Berlin, Germany PubMed articlesGoogle scholar articles
  • Leonie Maria Frommert Department of Rheumatology and Clinical Immunology, Charité Universitätsmedizin Berlin Campus Charite Mitte, Berlin, Germany PubMed articlesGoogle scholar articles
  • Florian Kurth Department of Infectious Diseases and Respiratory Medicine, Charité Universitätsmedizin Berlin Campus Charite Mitte, Berlin, Germany PubMed articlesGoogle scholar articles
  • Leif Erik Sander Department of Infectious Diseases and Respiratory Medicine, Charité Universitätsmedizin Berlin Campus Charite Mitte, Berlin, Germany PubMed articlesGoogle scholar articles
  • Gerd R Burmester Department of Rheumatology and Clinical Immunology, Charité Universitätsmedizin Berlin Campus Charite Mitte, Berlin, Germany PubMed articlesGoogle scholar articles
  • Florian Klein Laboratory of Experimental Immunology, Institute of Virologie, University Hospital Cologne, 50931 Cologne, GermanyCenter for Molecular Medicine Cologne (CMMC), University of Cologne, 50931 Cologne, GermanyPartner site Bonn-Cologne, German Centre for Infection Research, 50931 Cologne, Germany PubMed articlesGoogle scholar articles
  • Robert Biesen Department of Rheumatology and Clinical Immunology, Charité Universitätsmedizin Berlin Campus Charite Mitte, Berlin, Germany PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Robert Biesen; Robert.biesen{at}charite.de
View Full Text

Citation

Habermann E, Gieselmann L, Tober-Lau P, et al
Pausing methotrexate prevents impairment of Omicron BA.1 and BA.2 neutralisation after COVID-19 booster vaccination

Publication history

  • Received August 3, 2022
  • Accepted September 12, 2022
  • First published October 10, 2022.
Online issue publication 
October 10, 2022
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.